Tuesday, March 31, 2020

Deadline now extended for PSA’s discussion paper

The Pharmaceutical Society of Australia (PSA) is extending its deadline for the ‘Pharmacists in 2023’ discussion paper to next Friday (September 14).

In response to stakeholder requests, PSA is extending the consultation period on the paper (http://www.psa.org.au/wp-content/uploads/Pharmacists-in-2023-Discussion-Paper.pdf) from the original deadline of today (September 7).

“We have already received a number of incredibly detailed submissions and want to ensure all stakeholders have enough time to address the important issues of embedding, equipping and enabling pharmacists,” PSA General Manager, Policy & Advocacy Belinda Wood said.

“If you are interested in shaping the future of the pharmacist profession, PSA encourages you to make a submission.”


Must Read

MedAdvisor launches telehealth services

MedAdvisor is extending its GP Link technology to enable patients to undertake telehealth consultations with their GP or one of MedAdvisor’s On-Demand GPs. The move...